149 related articles for article (PubMed ID: 8848852)
1. [Interaction between warfarin and nalidic acid].
Gulløv AL; Koefoed BG; Petersen P
Ugeskr Laeger; 1996 Sep; 158(37):5174-5. PubMed ID: 8848852
[TBL] [Abstract][Full Text] [Related]
2. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
Knudsen JF; Sokol GH
Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
[TBL] [Abstract][Full Text] [Related]
3. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
[TBL] [Abstract][Full Text] [Related]
4. Probable interaction between warfarin and marijuana smoking.
Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
[TBL] [Abstract][Full Text] [Related]
5. Enhanced hypoprothrombinemia with warfarin due to azithromycin.
Rao KB; Pallaki M; Tolbert SR; Hornick TR
Ann Pharmacother; 2004 Jun; 38(6):982-5. PubMed ID: 15084685
[TBL] [Abstract][Full Text] [Related]
6. [Interaction between warfarin and coenzyme Q10].
Landbo C; Almdal TP
Ugeskr Laeger; 1998 May; 160(22):3226-7. PubMed ID: 9621803
[TBL] [Abstract][Full Text] [Related]
7. [Interaction between warfarin and oral miconazole gel].
Ogard CG; Vestergaard H
Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
[TBL] [Abstract][Full Text] [Related]
8. [Long-term drug interaction of warfarin with amiodarone].
Hirmerová J; Suchý D; Mádr T
Cas Lek Cesk; 2003 Jan; 142(1):39-42. PubMed ID: 12693297
[TBL] [Abstract][Full Text] [Related]
9. Interaction between warfarin and nafcillin: case report and review of the literature.
Kim KY; Frey RJ; Epplen K; Foruhari F
Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
[TBL] [Abstract][Full Text] [Related]
10. Interaction of doxycycline and warfarin: an enhanced anticoagulant effect.
Hasan SA
Cornea; 2007 Jul; 26(6):742-3. PubMed ID: 17592328
[TBL] [Abstract][Full Text] [Related]
11. Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin.
Kamali F; Khan TI; King BP; Frearson R; Kesteven P; Wood P; Daly AK; Wynne H
Clin Pharmacol Ther; 2004 Mar; 75(3):204-12. PubMed ID: 15001972
[TBL] [Abstract][Full Text] [Related]
12. Frequency of concurrent use of warfarin with potentially interacting drugs.
Wittkowsky AK; Boccuzzi SJ; Wogen J; Wygant G; Patel P; Hauch O
Pharmacotherapy; 2004 Dec; 24(12):1668-74. PubMed ID: 15585436
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide and warfarin interaction: case report and review of the literature.
Chonlahan J; Halloran MA; Hammonds A
Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
[TBL] [Abstract][Full Text] [Related]
14. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
15. Interactions between warfarin and three commonly prescribed fluoroquinolones.
Carroll DN; Carroll DG
Ann Pharmacother; 2008 May; 42(5):680-5. PubMed ID: 18413687
[TBL] [Abstract][Full Text] [Related]
16. Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.
Howard-Thompson A; Hurdle AC; Arnold LB; Finch CK; Sands C; Self TH
Am J Geriatr Pharmacother; 2008 Mar; 6(1):33-6. PubMed ID: 18396247
[TBL] [Abstract][Full Text] [Related]
17. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
18. Clinical factors influencing the sensitivity to warfarin when restarted after surgery.
Schulman S; El Bouazzaoui B; Eikelboom JW; Zondag M
J Intern Med; 2008 Apr; 263(4):412-9. PubMed ID: 18205763
[TBL] [Abstract][Full Text] [Related]
19. Chitosan potentiation of warfarin effect.
Huang SS; Sung SH; Chiang CE
Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
[TBL] [Abstract][Full Text] [Related]
20. Decreased INR response secondary to warfarin-flucloxacillin interaction.
Garg A; Mohammed M
Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
